-
EP1732548
European procedure
Extract from the Register of European Patents
EP About this file: EP1732548
| EP1732548 - METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS [Right-click to bookmark this link] | |||
| Status | Patent maintained as amended Status updated on 28.07.2023 Database last updated on 14.03.2025 | ||
| Most recent event Tooltip | 28.07.2023 | Patent maintained (B2 publication) | published on 30.08.2023 [2023/35] |
| Applicant(s) | For all designated states Acorda Therapeutics, Inc. 420 Saw Mill River Road Ardsley, NY 10502 / US | ||
| [2013/11] | |||
| Former [2006/51] | For all designated states Acorda Therapeutics, Inc. 15 Skyline Drive Hawthorne NY 10531 / US | ||
| Inventor(s) | 01 /
BLIGHT, Andrew, R. 10 Oskar Drive Mahopac, NY 10541 / US | ||
| 02 /
MARINUCCI, Lawrence 25 Bank Street Apartment 214H White Plains, NY 10606 / US | |||
| 03 /
COHEN, Ron 246 Harriman Road Irvington, NY 10533 / US | |||
| [2023/35] | |||
| Former [2006/51] | 01 /
BLIGHT, Andrew, R. 10 Oskar Drive Mahopac, NY 10541 / US | ||
| 02 /
MARINUCCI, Lawrence 25 Bank Street Apartment 214H White Plains, NY 10606 / US | |||
| 03 /
COHEN, Ron 246 Harriman Road Irvington, NY 10533 / US | |||
| Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | ||
| [2023/35] | |||
| Former [2012/19] | Goodfellow, Hugh Robin, et al Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB | ||
| Former [2009/48] | Ouzman, Beverley Nicola Claire, et al Murgitroyd & Company Scotland House 165-169 Scotland Street Glasgow G5 8PL / GB | ||
| Former [2006/51] | Ouzman, Beverley Nicola Claire, et al Murgitroyd and Company, 165-169 Scotland Street Glasgow G5 8PL / GB | ||
| Application number, filing date | 05732613.4 | 11.04.2005 | |
| [2006/51] | |||
| WO2005US12427 | |||
| Priority number, date | US20040560894P | 09.04.2004 Original published format: US 560894 P | |
| US20050102559 | 08.04.2005 Original published format: US 102559 | ||
| [2006/51] | |||
| Filing language | EN | ||
| Procedural language | EN | ||
| Publication | Type: | A2 Application without search report | |
| No.: | WO2005099701 | ||
| Date: | 27.10.2005 | ||
| Language: | EN | ||
| [2005/43] | |||
| Type: | A2 Application without search report | ||
| No.: | EP1732548 | ||
| Date: | 20.12.2006 | ||
| Language: | EN | ||
| The application published by WIPO in one of the EPO official languages on 27.10.2005 takes the place of the publication of the European patent application. | |||
| [2006/51] | |||
| Type: | B1 Patent specification | ||
| No.: | EP1732548 | ||
| Date: | 08.06.2011 | ||
| Language: | EN | ||
| [2011/23] | |||
| Type: | B9 Corrected patent specification | ||
| No.: | EP1732548 | ||
| Date: | 21.03.2012 | ||
| [2012/12] | |||
| Type: | B2 New European patent specification | ||
| No.: | EP1732548 | ||
| Date: | 30.08.2023 | ||
| Language: | EN | ||
| [2023/35] | |||
| Search report(s) | International search report - published on: | US | 23.03.2006 |
| (Supplementary) European search report - dispatched on: | EP | 07.05.2009 | |
| Classification | IPC: | A61K31/44 | [2006/51] |
| CPC: |
A61K31/4409 (EP,US);
A61K31/435 (EP,US);
A61K31/44 (EP,US);
A61K9/20 (US);
A61P17/02 (EP);
A61P19/08 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P43/00 (EP)
(-)
| ||
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2023/35] | ||
| Former [2006/51] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | ||
| Extension states | AL | 09.10.2006 | |
| BA | 09.10.2006 | ||
| HR | 09.10.2006 | ||
| LV | 09.10.2006 | ||
| MK | 09.10.2006 | ||
| YU | 09.10.2006 | ||
| Title | German: | VERFAHREN ZUR VERWENDUNG VON AMINOPYRIN-ZUSAMMENSETZUNGEN MIT VERZÖGERTER FREISETZUNG | [2010/45] |
| English: | METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS | [2006/51] | |
| French: | UTILISATION DE COMPOSITIONS D'AMINOPYRIDINE A LIBERATION SOUTENUE | [2006/51] | |
| Former [2006/51] | VERFAHREN ZUR VERWENDUNG VON AMINOPYRIN-ZUSAMMENSETZUNG MIT VERZÖGERTER FREISETZUNG | ||
| Entry into regional phase | 09.10.2006 | National basic fee paid | |
| 09.10.2006 | Search fee paid | ||
| 09.10.2006 | Designation fee(s) paid | ||
| 09.10.2006 | Examination fee paid | ||
| Examination procedure | 09.10.2006 | Amendment by applicant (claims and/or description) | |
| 09.10.2006 | Examination requested [2006/51] | ||
| 27.08.2009 | Despatch of a communication from the examining division (Time limit: M04) | ||
| 16.10.2009 | Reply to a communication from the examining division | ||
| 26.10.2009 | Despatch of a communication from the examining division (Time limit: M04) | ||
| 05.03.2010 | Reply to a communication from the examining division | ||
| 30.03.2010 | Despatch of a communication from the examining division (Time limit: M02) | ||
| 12.04.2010 | Reply to a communication from the examining division | ||
| 12.11.2010 | Communication of intention to grant the patent | ||
| 17.03.2011 | Fee for grant paid | ||
| 17.03.2011 | Fee for publishing/printing paid | ||
| Divisional application(s) | EP11160247.0 / EP2377536 | ||
| EP11168901.4 / EP2422782 | |||
| EP11179067.1 / EP2460521 | |||
| EP21170762.5 / EP3922248 | |||
| The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.08.2009 | |||
| Opposition(s) | Opponent(s) | 01
07.03.2012
14.03.2012
ADMISSIBLE Synthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Benneker, Franciscus B. G., et al, et al Synthon BV Microweg 22 6545 CM Nijmegen / NL | |
| 02
08.03.2012
23.03.2012
ADMISSIBLE neuraxpharm Arzneimittel GmbH Elisabeth-Selbert-Str. 23 40764 Langenfeld / DE Opponent's representative Königer, Karsten, et al, et al Harmsen Utescher Rechtsanwalts- und Patentanwaltspartnerschaft mbB Neuer Wall 80 20354 Hamburg / DE | |||
| [2023/27] | |||
| Former [2013/22] | |||
| Opponent(s) | 01
07.03.2012
14.03.2012
ADMISSIBLE Synthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL | ||
| 02
08.03.2012
23.03.2012
ADMISSIBLE neuraxpharm Arzneimittel GmbH Elisabeth-Selbert-Str. 23 40764 Langenfeld / DE Opponent's representative Königer, Karsten, et al, et al Harmsen Utescher Rechtsanwälte Patentanwälte Neuer Wall 80 D-20354 Hamburg / DE | |||
| Former [2012/16] | |||
| Opponent(s) | 01
07.03.2012
14.03.2012
ADMISSIBLE Synthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem, et al, et al Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL | ||
| 02
08.03.2012
ADMISSIBLE neuraxpharm Arzneimittel GmbH & Co. KG Elisabeth-Selbert-Strasse 23 40764 Langenfeld / DE Opponent's representative Königer, Karsten Harmsen Utescher Rechtsanwälte Patentanwälte Neuer Wall 80 D-20354 Hamburg / DE | |||
| Former [2012/15] | |||
| Opponent(s) | 01
07.03.2012
ADMISSIBLE Synthon B.V. Microweg 22 6545 CM Nijmegen / NL Opponent's representative Prins, Hendrik Willem Arnold & Siedsma Sweelinckplein 1 2517 GK The Hague / NL | ||
| 16.04.2012 | Invitation to proprietor to file observations on the notice of opposition | ||
| 02.01.2013 | Reply of patent proprietor to notice(s) of opposition | ||
| 11.11.2013 | Date of oral proceedings | ||
| 19.12.2013 | Despatch of minutes of oral proceedings | ||
| 09.03.2021 | Despatch of a communication from the opposition division (Time limit: M02) | ||
| 16.03.2021 | Reply to a communication from the opposition division | ||
| 22.11.2021 | Despatch of a communication from the opposition division (Time limit: M02) | ||
| 01.02.2022 | Reply to a communication from the opposition division | ||
| 14.04.2022 | Despatch of a communication from the opposition division (Time limit: M02) | ||
| 20.06.2022 | Reply to a communication from the opposition division | ||
| 02.08.2022 | Despatch of a communication from the opposition division (Time limit: M02) | ||
| 08.02.2023 | Despatch of interlocutory decision in opposition | ||
| 18.02.2023 | Legal effect of interlocutory decision in opposition | ||
| 06.06.2023 | Despatch of communication that the patent will be maintained as amended | ||
| 26.07.2023 | Fee for printing new specification paid | ||
| Appeal following opposition | 27.02.2014 | Appeal received No. T0421/14 | |
| 29.04.2014 | Statement of grounds filed | ||
| 03.09.2019 | Result of appeal procedure: maintenance in amended form | ||
| 17.02.2014 | Appeal received No. T0421/14 | ||
| 28.04.2014 | Statement of grounds filed | ||
| 03.09.2019 | Result of appeal procedure: maintenance in amended form | ||
| 02.09.2019 | Date of oral proceedings | ||
| 11.09.2019 | Minutes of the oral proceedings despatched | ||
| Fees paid | Renewal fee | ||
| 27.04.2007 | Renewal fee patent year 03 | ||
| 25.04.2008 | Renewal fee patent year 04 | ||
| 29.04.2009 | Renewal fee patent year 05 | ||
| 26.04.2010 | Renewal fee patent year 06 | ||
| 25.04.2011 | Renewal fee patent year 07 | ||
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Documents cited: | Search | [X]IE82916 (ELAN CORP PLC); | |
| International search | [X]EP0484186 (ELAN CORP PLC [IE]); | ||
| other | US8007826 | ||
| EP2377536 | |||
| US8663685 | |||